Apontis Pharma AG — Director's Dealing 2024

Dec 12, 2024

News Details

Directors’ Dealings | 11 December 2024 14:42

APONTIS PHARMA AG: Thomas Milz, Sale: The sale was made via a joint custody account with Ariane Milz (person closely associated with a person discharging managerial responsibilities).

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

11.12.2024 / 14:41 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Thomas
Last name(s):	Milz

2. Reason for the notification

a) Position / status

Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

APONTIS PHARMA AG

b) LEI

894500ETO1J6MR8PDF91

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A40KY75

b) Nature of the transaction

Sale: The sale was made via a joint custody account with Ariane Milz (person closely associated with a person discharging managerial responsibilities).

c) Price(s) and volume(s)

Price(s)	Volume(s)
10.00 EUR	1,058,970.00 EUR

d) Aggregated information

Price	Aggregated volume
10.00 EUR	1,058,970.00 EUR

e) Date of the transaction

2024-12-04; UTC+1

f) Place of the transaction

Outside a trading venue

---

11.12.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	APONTIS PHARMA AG
	Rolf-Schwarz-Schütte-Platz 1
	40789 Monheim am Rhein
	Germany
Internet:	https://apontis-pharma.de/

End of News	EQS News Service